Cargando…
Comparison of Serum Beta 2-Microglobulin and 24 hour Urinary Creatinine Clearance as a Prognostic Factor in Multiple Myeloma
A new staging system for multiple myeloma (MM) has utilized serum concentrations of beta 2-microglobulin (Sβ(2)M) and albumin as important prognostic factors for survival. Since Sβ(2)M is an indicator of glomerular filtration rate, we compared the prognostic values of Sβ(2)M and 24-hr urinary creati...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729884/ https://www.ncbi.nlm.nih.gov/pubmed/16891806 http://dx.doi.org/10.3346/jkms.2006.21.4.639 |
Sumario: | A new staging system for multiple myeloma (MM) has utilized serum concentrations of beta 2-microglobulin (Sβ(2)M) and albumin as important prognostic factors for survival. Since Sβ(2)M is an indicator of glomerular filtration rate, we compared the prognostic values of Sβ(2)M and 24-hr urinary creatinine clearance (Ccr) in patients with MM. We retrospectively reviewed the records of 170 MM patients from January 1996 to November 2003 whose 24-hr urinary Ccr was available at the time of diagnosis. We found that pretreatment Sβ(2)M was inversely related to Ccr (Spearman's correlation coefficient=-0.787). In univariate analysis, the hazard ratio (HR) of death was 1.043 (p<0.001) for Sβ(2)M and 0.985 (p<0.001) for Ccr. Multivariate analysis showed that Sβ(2)M (HR 1.030, p=0.010) and Ccr (HR 0.993, p=0.059) were significant prognostic factors in patients' survival. In conclusion, 24-hr urinary Ccr may be utilized for staging of patients with MM. |
---|